Mirna-486 Regulates Angiogenic Activity and Survival of Mesenchymal Stem Cells under Hypoxia Through Modulating Akt Signal

Xue-Feng Shi,Hua Wang,Feng-Jun Xiao,Yue Yin,Qin-Qin Xu,Ri-Li Ge,Li-Sheng Wang
DOI: https://doi.org/10.1016/j.bbrc.2016.01.084
IF: 3.1
2016-01-01
Biochemical and Biophysical Research Communications
Abstract:MicroRNA-486 (miR-486) was first identified from human fetal liver cDNA library and validated as a regulator of hematopoiesis. Its roles in regulating the biological function of bone marrow-derived mesnechymal stem cells (BM-MSCs) under hypoxia have not been explored yet. In this study, we demonstrated that exposure to hypoxia upregulates miR-486 expression in BM-MSCs. Lentivirus-mediated overexpression of miR-486 resulted in increase of hepatocyte growth factor (HGF) and vascular endothelial growth factor(VEGF) in both mRNA and protein levels. MiR-486 expression also promotes proliferation and reduces apoptosis of BM-MSCs. Whereas MiR-486 knockdown downregulated the secretion of HGF and VEGF and induced apoptosis of BM-MSCs. Furthermore, PTEN-PI3K/AKT signaling was validated to be involved in changes of BM-MSC biological functions regulated by miR-486. These results suggested that MiR-486 mediated the hypoxia-induced angiogenic activity and promoted the proliferation and survival of BM-MSCs through regulating PTEN-PI3K/AKT signaling. These findings might provide a novel understanding of effective therapeutic strategy for hypoxic-ischemic diseases.
What problem does this paper attempt to address?